InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Romano Sarah, Directrice Financière. Officer active across 2 companies, notably Eyegate Pharmaceuticals INC. Aggregated, 20 disclosures have been logged. The latest transaction was filed on 10 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations20 total
€65108 shares@ €0.604123.4% of flow
Common Stock
SEC:0001104659-22-020560·
€65108 shares@ €0.604111.7% of flow
Common Stock
SEC:0001104659-22-020560:0·
€109114 shares@ €0.957139.1% of flow
Common Stock
SEC:0001104659-22-001943·
€109114 shares@ €0.957119.5% of flow
Common Stock
SEC:0001104659-22-001943:0·
€10591 shares@ €1.151837.5% of flow
Common Stock
SEC:0001104659-21-147635·
€10591 shares@ €1.151818.8% of flow
Common Stock
SEC:0001104659-21-147635:0·
€14283 shares@ €1.7075.9% of flow
Common Stock
SEC:0001104659-21-133650·
€14283 shares@ €1.7073.0% of flow
Common Stock
SEC:0001104659-21-133650:0·
€14483 shares@ €1.736.0% of flow
Common Stock
SEC:0001104659-21-123267·
€14483 shares@ €1.733.0% of flow
Common Stock
SEC:0001104659-21-123267:0·
€12884 shares@ €1.5245.4% of flow
Common Stock
SEC:0001104659-21-112940·
€12884 shares@ €1.5242.7% of flow
Common Stock
SEC:0001104659-21-112940:0·
€17687 shares@ €2.0227.4% of flow
Common Stock
SEC:0001104659-21-100196·
€17687 shares@ €2.0223.7% of flow
Common Stock
SEC:0001104659-21-100196:0·
€562180 shares@ €3.123423.6% of flow
Common Stock
SEC:0001104659-21-089447·
€562180 shares@ €3.123411.8% of flow
Common Stock
SEC:0001104659-21-089447:0·
€622180 shares@ €3.453426.1% of flow
Common Stock
SEC:0001104659-21-077765·
€622180 shares@ €3.453413.1% of flow
Common Stock
SEC:0001104659-21-077765:0·
€608177 shares@ €3.437425.5% of flow
Common Stock
SEC:0001104659-21-061949·
€608177 shares@ €3.437412.8% of flow
Common Stock
SEC:0001104659-21-061949:0·
20 of 20 declarations
About Romano Sarah
Sarah Romano is associated with EYEGATE PHARMACEUTICALS INC.
